Tonsillar abscess formation due to herpes simplex type-1 in a severely immunocompromised stem cell transplant patient with chronic myeloid leukemia

Transplant Infectious Disease

Volumn 8, Issue 3, 2006, Pages 166-170

  Gonen, C ^a,b   Uner, A ^a   Cetinkaya, Y ^a   Hascelik, G ^a   Haznedaroglu, I ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Ilica Mahallesi ^*  (Turkey)

Author keywords

Abscesses; Herpes simplex; Tonsillitis

Indexed keywords

ALLOPURINOL; AMIKACIN; AMPHOTERICIN B; ANTIINFECTIVE AGENT; CEFEPIME; CYTARABINE; FLUCONAZOLE; HYDROXYUREA; IDARUBICIN; VANCOMYCIN;

ABSCESS; ADULT; ANTIMICROBIAL THERAPY; APHERESIS; ARTICLE; BLOOD CULTURE; CASE REPORT; CELLULITIS; CHRONIC MYELOID LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; INCISION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TONSILLITIS;

ADULT; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, MYELOID, CHRONIC; MALE; PERITONSILLAR ABSCESS; STEM CELL TRANSPLANTATION;

EID: 33746907056     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2006.00131.x     Document Type: Article

References (15)

1. COREY L. Herpes simplex virus. In: MANDELL GL, BENNETT JE, DOLIN R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases (5th edn). Philadelphia: Churchill Livingstone, 2000: 1564-1580.
2. WAT PJ, STRICKLER JG, MYERS JL, NORDSTROM MR. Herpes simplex infection causing acute necrotizing tonsillitis. Mayo Clin Proc 1994: 69: 269-271.
3. BRADFORD D. Disseminated herpes simplex virus infection. Med J Aust 1990: 152: 167.
4. KATZ J, PERETZ B. Trismus in a 6 year old child: a manifestation of leukemia? J Clin Pediatr Dent 2002: 26: 337-340.
5. FULP SR, NESTOK BR, POWELL BL, EVANS JK, GEISINGER KR, GILLIAM JH. Leukemic infiltration of the esophagus. Cancer 1993: 71: 112-116.
6. SKLANSKY BD, JAFEK BW, WIERNIK PH. Otolaryngologic manifestations of acute leukemia. Laryngoscope 1974: 84: 210-230.
7. STRICKLER JG, MANIVEL JC, COPENHAVER CM, KUBIC VL. Comparison of in situ hybridization and immunohistochemistry for detection of cytomegalovirus and herpes simplex virus. Hum Pathol 1990: 21: 443-448.
8. ESPY MJ, UHL JR, MITCHELL PS, et al. Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol 2000: 38: 795-799.
9. HUGHES WT, ARMSTRONG D, BODEY GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002: 34: 730-751.
10. EISEN D, ESSELL J, BROUN ER, SIGMUND D, DEVOE M. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy. Bone Marrow Transplant 2003: 31: 51-55.
11. LIESVELD JL, ABBOUD CN, IFTHIKHARUDDIN JJ, et al. Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients. Biol Blood Marrow Transplant 2002: 8: 662-665.
12. DIGNANI MC, MYKIETIUK A, MICHELET M, et al. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation. Bone Marrow Transplant 2002: 29: 263-267.
13. ORLOWSKI RZ, MILLS SR, HARTLEY EE, et al. Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemia. Leuk Lymphoma 2004: 45: 2215-2219.
14. MOLONEY M, PRINCE HM, SEYMOUR JF, SLAVIN M, DOOLEY M. Dosing schedule of oral valacyclovir for prevention of herpes simplex virus. Bone Marrow Transplant 2003: 32: 1035.
15. DYKEWICZ CA. Centers for Disease Control and Prevention (U.S.); Infectious Diseases Society of America; American Society of Blood and Marrow Transplantation. Summary of the guidelines for preventing opportunistic infections among hematopoietic stemcell transplant recipients. Clin Infect Dis 2001: 33: 139-144.